Pharmacokinetics fosinopril patients various degrees renal function Single-dose kinetics fosinopril new phosphorus-containing angiotensin-converting enzyme inhibitor active diacid fosinoprilat patients mild moderate severe renal impairment normal renal function intravenous dose mg total body clearance fosinoprilat patients normal renal function impaired patients degree renal impairment patients creatinine clearance values renal clearance increases hepatic clearance total clearance oral mg plasma kinetics bioavailability fosinoprilat similar groups impaired patients dual elimination fosinoprilat liver kidney distinguishes angiotensin-converting enzyme inhibitors 